Microultrasonography for prostate biopsy detected clinically significant cancer at rates comparable to MRI-guided approaches. Detection rates for clinically insignificant cancers did not differ among ...

High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a ...

A trial found no meaningful difference in detection of clinically significantly prostate cancer between multiparametric MRI-based and microultrasound-based biopsy techniques.

GRENOBLE, France and PRINCETON, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Koelis, SAS ("Koelis" or the "Company", www.koelis.com), a leader and innovator in MRI-ultrasound fusion guidance for prostate ...

Called a transperineal biopsy, the procedure is combined with 3D MRI fusion guided technology to highlight prostate cancer. It is the latest urological cancer diagnostic tool to be added to an ...

GRENOBLE, France, March 12, 2026 (GLOBE NEWSWIRE)-- Koelis, SAS ("Koelis" or the "Company", www.koelis.com), a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, ...

Cognitive fusion biopsy performs best in lean men, whereas software-assisted targeted biopsy has diagnostic advantages in obese men. For detecting clinically significant prostate cancer, cognitive ...

A prostate biopsy is a procedure to remove small samples of tissue from the prostate gland. It's a method to test for prostate cancer if a prostate-specific antigen (PSA) blood test or digital rectal ...